Is ORGO a Buy, Before Earnings?
PremiumPre-EarningsIs ORGO a Buy, Before Earnings?
3d ago
Organogenesis trial results show safety, efficacy of NuShield for  DFUs
Premium
The Fly
Organogenesis trial results show safety, efficacy of NuShield for DFUs
1M ago
Organogenesis announces development program update for ReNu
Premium
The Fly
Organogenesis announces development program update for ReNu
3M ago
Organogenesis sees FY24 revenue $445M-$470M, consensus $454.69M
PremiumThe FlyOrganogenesis sees FY24 revenue $445M-$470M, consensus $454.69M
6M ago
Organogenesis reports Q1 EPS (2c), consensus (3c)
Premium
The Fly
Organogenesis reports Q1 EPS (2c), consensus (3c)
6M ago
Organogenesis achieves primary endpoint in Phase 3 trial of ReNu
Premium
The Fly
Organogenesis achieves primary endpoint in Phase 3 trial of ReNu
6M ago
Organogenesis initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyOrganogenesis initiated with an Overweight at Cantor Fitzgerald
9M ago
Organogenesis price target raised to $6 from $4 at BTIG
Premium
The Fly
Organogenesis price target raised to $6 from $4 at BTIG
11M ago
BTIG sees a win for Organogenesis from MAC decision on LCDs
Premium
The Fly
BTIG sees a win for Organogenesis from MAC decision on LCDs
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100